Optiray (Ioversol)

Ioversol, the active ingredient in Optiray, is an iodinated contrast agent presented as a solution for injection for intraarterial and intravenous use. It provides radiographic contrast to enhance the visibility of vascular structures and organs during diagnostic imaging procedures. GNH USA supplies Optiray as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Optiray (ioversol) is used as an iodinated contrast medium in radiographic procedures to improve visualization of vascular and organ structures. - Angiography: enhances the delineation of blood vessels for accurate assessment. - Computed tomography (CT) imaging: provides contrast to differentiate tissues and detect lesions. - Urography: improves imaging of the urinary tract for diagnosis of obstruction or disease. - Cystography: facilitates clear visualization of the bladder. - Myelography: aids in detailed imaging of the spinal canal and nerve roots.

Adverse reactions may occur following administration of iodinated contrast agents such as ioversol.

Common Side Effects: - Warmth or flushing sensation during injection. - Metallic taste in the mouth. - Mild nausea or vomiting. - Transient headache. - Mild urticaria or skin itching. - Temporary increase in blood pressure.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Contrast‑induced nephropathy leading to renal impairment. - Hypotension or cardiovascular collapse. - Pulmonary edema or respiratory distress. - Seizures or neurological disturbances. - Cardiac arrhythmias.

Use of Optiray requires careful assessment of patient risk factors and appropriate preparation. - Renal function assessment: evaluate serum creatinine and eGFR before administration. - Allergy history: screen for prior reactions to iodinated contrast or related substances. - Hydration: ensure adequate fluid intake to reduce nephrotoxic risk. - Dose minimization: use the lowest effective volume for the intended imaging study. - Thyroid monitoring: consider iodine load effects in patients with thyroid disorders. - Store at ambient temperature: keep below 25°C, protect from moisture and light, and retain in original packaging.

Ioversol may interact with other medications, affecting safety and efficacy.

Major Interactions (Avoid): - Nephrotoxic agents (e.g., aminoglycosides, high‑dose NSAIDs): increase risk of renal injury. - Iodine‑containing drugs (e.g., amiodarone, thyroid hormone): may exacerbate thyroid dysfunction. - Metformin: risk of lactic acidosis in renal impairment; consider temporary discontinuation.

Moderate Interactions (Monitor Closely): - Diuretics: may alter fluid balance and affect contrast distribution. - Beta‑blockers: can mask hypotensive responses. - ACE inhibitors or ARBs: may increase susceptibility to contrast‑induced nephropathy. - Anticoagulants: heightened bleeding risk during invasive imaging procedures.